Dharmesh Bhakta
Podiatrist · Arlington, TXNPI 1346243243
Payments from drug & device makers
What this record shows
This record is dominated by royalties or licence payments: $96,250 of the $105,024 with a category attached, or 91.6%. Fuse Medical, Inc. accounts for 91.6% of it on its own, with 32 other manufacturers making up the rest. Reporting peaked in 2023 at $58,434 and has fallen 99.3% since, to $402 in 2025. Among podiatrist clinicians in TX with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 132 payments — averaging $795.64 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Fuse Medical, Inc.$96K
- Biogennix, LLC$2K
- Melinta Therapeutics, LLC$2K
- Stryker$1K
- Medical Device Business Services, Inc.$936
- Bone Support Inc.$759
- plus $2K from 27 others
What the payments were for
- Royalty or licence$96,25092%
- Consulting fees$5000%
- Speaking & faculty fees$2,8753%
- Travel & lodging$8521%
- Food & beverage$4,5124%
- Education$350%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Fuse Medical, Inc. | 2 | $96,250 |
| Biogennix, LLC | 4 | $2,213 |
| Melinta Therapeutics, LLC | 6 | $2,025 |
| Stryker(2 entities) | 51 | $1,312 |
| Medical Device Business Services, Inc. | 5 | $936 |
| Bone Support Inc. | 6 | $759 |
| Integra Lifesciences Corporation | 12 | $500 |
| Medtronic | 1 | $117 |
| Amgen | 5 | $94 |
| Reprise Biomedical, Inc. | 3 | $71 |
| Nevro Corp. | 2 | $66 |
| Linvatec Corporation | 1 | $59 |
| Smith+Nephew | 4 | $56 |
| Zyla Life Sciences, Inc. | 4 | $55 |
| Pacira Pharmaceuticals Incorporated | 3 | $55 |
| Abbott | 3 | $51 |
| Bioventus LLC | 2 | $51 |
| Averitas Pharma Inc. | 1 | $45 |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 2 | $34 |
| Misonix Inc | 1 | $33 |
| Paratek Pharmaceuticals, Inc. | 2 | $30 |
| CPM Medical Consultants, LLC | 1 | $29 |
| Johnson & Johnson | 1 | $24 |
| IBSA Pharma Inc. | 1 | $23 |
| Organogenesis Inc. | 1 | $21 |
| Heron Therapeutics, Inc. | 1 | $20 |
| Maruho Medical, Inc. | 1 | $18 |
| Kowa Pharmaceuticals America, Inc. | 1 | $15 |
| Polynovo North America LLC | 1 | $15 |
| Baudax Bio Inc. | 1 | $15 |
| Merck | 1 | $12 |
| Tactile Systems Technology Inc | 1 | $12 |
| Orthofix Medical, Inc. | 1 | $10 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Fuse ULTRA Foot plating System$96,250
- Baxdela$1,978
- Agilon$1,493
- EXTERNAL FIXATION$852
- CERAMENTBONE VOID FILLER$732
- CERAMENT G$732
- Agilon Surgical Matrix$720
- INTEGRA$359
- INFINITY$148
- INFINITY ADAPTIS$139
- INTEGRA DERMAL REGENERATION TEMPLATE$120
- PRIMATRIX$120
- TurboHawk$117
How this compares
$105,024 in reported general payments places this provider in the 95th percentile of 470 podiatrist providers in Texas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Betamethasone Diprop AugmentedBetamethasone/Propylene Glyc | 21 | $2,319 |
| Diclofenac Sodium | 15 | $2,171 |
| Pregabalin | 41 | $1,618 |
| Lidocaine-PrilocaineLidocaine/Prilocaine | 55 | $1,394 |
| Ciclopirox | 48 | $1,155 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 113 | $969 |
| Gabapentin | 41 | $699 |
| Cephalexin | 88 | $453 |
| Triamcinolone Acetonide | 39 | $245 |
| Terbinafine Hcl | 30 | $236 |
| Ketoconazole | 13 | $219 |
| Clindamycin Hcl | 21 | $120 |
| Methylprednisolone | 14 | $119 |
| Mupirocin | 12 | $90 |
| Tramadol Hcl | 15 | $56 |
Paid to pharmacies, not to this prescriber.
Other podiatrist in Arlington
- Brian CarpenterFort Worth$1.2M
- Gary LepowHouston$1M
- Wayne HurstCedar Park$625K
- Calvin RushingSunnyvale$452K
- Alan GarrettFort Worth$185K
- Gregory JarygaFt Worth$175K
- Brandon LampeMesquite$154K
- Andrew SchneiderHouston$150K
- Patrick BriggsWebster$133K
- Richard AdamsGranbury$130K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.